Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats

European Journal of Pharmacology

Volumn 352, Issue 2-3, 1998, Pages 171-178

  Yamamoto, Yasuchika ^a,b   Yasuda, Yoshinobu ^a   Kimura, Yukio ^a   Komiya, Yoshiaki ^b  

^a Thromb and Vasc Res Laboratory   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Antiplatelet vasodilating agent; Axonal regeneration; Cilostazol; Nerve injury; Ornithine decarboxylase; Phosphodiesterase inhibitor; Streptozotocin diabetic rat

Indexed keywords

ANTITHROMBOCYTIC AGENT; CILOSTAZOL; ORNITHINE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; MALE; NERVE FIBER REGENERATION; NERVE INJURY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL GANGLION; STREPTOZOCIN DIABETES;

ANIMALS; AXONS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ENZYME INDUCTION; MALE; NERVE REGENERATION; ORNITHINE DECARBOXYLASE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; SCIATIC NERVE; STREPTOZOCIN; TETRAZOLES;

EID: 0031879620     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00356-2     Document Type: Article

References (36)

1. Bradley, J.L., Thomas, P.K., King, R.H., Muddle, J.R., Ward, J.D., Tesfaye, S., Boulton, A.J., Tsigos, C., Young, R.J., 1995. Myelinated nerve fibre regeneration in diabetic sensory polyneuropathy: correlation with type of diabetes. Acta Neuropathol. (Berl) 90, 403-410.
2. Dahlin, L.B., 1995. Prevention of macrophage invasion impairs regeneration in nerve grafts. Brain Res. 679, 274-280.
3. Dyck, P.J., Lais, A., Karnes, J.L., O'Brien, P., Rizza, R., 1986. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann. Neurol. 19, 425-439.
4. Ekström, A.R., Tomlinson, D.R., 1989. Impaired nerve regeneration in streptozotocin-diabetic rats: Effects of treatment with an aldose reductase inhibitor. J. Neurol. Sci. 93, 231-237.
5. Gamse, R., Jancso, G., 1985. Reduced neurogenic inflammation in streptozotocin-diabetic rats due to microvascular changes but not to substance P depletion. Eur. J. Pharmacol. 118, 175-180.
6. Gilad, G.M., Gilad, V.H., 1983. Polyamine biosynthesis is required for survival of sympathetic neurons after axonal injury. Brain Res. 273, 191-194.
7. Greene, D.A., Lattimer, S.A., Carroll, P.B., Fernstrom, J.D., Finegold, D.N., 1990. A defect in sodium-dependent amino acid uptake in diabetic rabbit peripheral nerve: correction by an aldose reductase inhibitor or myo-inositol administration. J. Clin. Invest. 85, 1657-1665.
8. Greenbaum, D., Richardson, P.C., Salmon, M.V., Urich, H., 1964. Pathological observations on six cases of diabetic neuropathy. Brain 87, 201-208.
9. Kamijyo, M., Merry, A.C., Akdas, G., Cherian, P.V., Sima, A.A., 1996. Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: the effect of ARI treatment. J. Diab. Comp. 10, 183-191.
10. Kanje, M., Fransson, I., Edström, A., Löwkvist, B., 1986. Ornithine decarboxylase activity in dorsal root ganglia of regenerating frog sciatic nerve. Brain Res. 381, 24-28.
11. Kihara, M., Schmelzer, J.D., Low, P.A., 1995. Effect of cilostazol on experimental diabetic neuropathy in the rat. Diabetologia 38, 914-918.
12. Kilmer, S.L., Carlsen, R.C., 1987. Chronic infusion of agents that increase cyclic AMP concentration enhances the regeneration of mammalian peripheral nerves in vivo. Exp. Neurol. 95, 357-367.
13. Kimura, Y., Tani, T., Kanbe, T., Watanabe, K., 1985. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 35, 1144-1149.
14. Komiya, Y., 1980. Slowing with age of the rate of slow axonal flow in bifurcating axons of rat dorsal root ganglion cells. Brain Res. 183, 477-480.
15. Longo, F.M., Powell, H.C., Lebeau, J., Gerrero, M.R., Heckman, H., Myers, R.R., 1986. Delayed nerve regeneration in streptozotocin diabetic rats. Muscle Nerve 9, 385-393.
16. McLean, W.G., Chapman, J.E., Cullum, N.A., 1987. Impaired induction of ornithine decarboxylase activity following nerve crush in the streptozotocin-diabetic rat. Diabetologia 30, 963-965.
17. Myall, O.T., Allen, S.L., McLean, W.G., 1990. The effect of acrylamide on the induction of ornithine decarboxylasese the dorsal root ganglion of the rat. Brain Res. 523, 295-297.
18. Okuda, Y., Mizutani, M., Ikegami, T., Ueno, E., Yamashita, K., 1992. Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy. Arzneimittelforschung 42, 540-542.
19. Pekiner, C., McLean, W.G., 1990. Impaired induction of nerve ornithine decarboxylase activity in the streptozotocin-diabetic rat is prevented by the aldose reductase inhibitor ponalrestat. Br. J. Pharmacol. 101, 978-980.
20. Perry, V.H., Brown, M.C., Gordon, S., 1987. The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J. Exp. Med. 165, 1218-1223.
21. Russell, D.H., 1983. Microinjection of purified ornitine decarboxylase into xenopus oocytes selectively stimulates ribosomal RNA synthesis. Proc. Natl. Acad. Sci. U.S.A. 80, 1318-1321.
22. 125I-neve growth factor in rats with streptozotocin-induced diabetes. Diabetes 32, 654-663.
23. Sharma, A.K., Thomas, P.K., 1974. Peripheral nerve structure and function in experimental diabetes. J. Neurol. Sci. 23, 1-15.
24. Shindo, H., Tawata, M., Onaya, T., 1993. Cyclic adenosine 3′,5′-monophosphsphate enhances sodium, potassium-adenosine triphosphatase activity in the sciatic nerve of streptozotocin-induced diabetic rats. Endocrinology 132, 510-516.
25. Sidenius, P., Jakobsen, J., 1979. Axonal transport in early experimental diabetes. Brain Res. 173, 315-330.
26. Sima, A.A., Greene, D.A., Brown, M.B., Hohman, T.C., Hicks, D., Graepel, G.J., Bochenek, W.J., Beg, M., Gonen, B., 1993. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. J. Diab. Comp. 7, 157-169.
27. Tanaka, T., Ishikawa, T., Hagiwara, M., Onoda, K., Itoh, H., Hidaka, H., 1988. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology 36, 313-320.
28. Tani, T., Sakurai, K., Kimura, Y., Ishikawa, T., Hidaka, H., 1992. Pharmacological manipulation of tissue cyclic AMP by inhibitors: effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells. Adv. Second Messenger Phosphoprot. Res. 25, 215-228.
29. Tashiro, T., Komiya, Y., 1991. Changes in organization and axonal transport of cytoskeletal proteins during regeneration. J. Neurochem. 56, 1557-1563.
30. Tenor, H., Hatzelmann, A., Kupferschmidt, R., Stanciu, L., Djukanovic, R., Schudt, C., Wendel, A., Church, M.K., Shute, J.K., 1995. Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages. Clin. Exp. Allergy. 25, 625-633.
31. Thomas, P.K., Wright, D.W., Tzebelikos, E., 1984. Amino acid uptake by dorsal root ganglia from streptozotocin-diabetic rats. J. Neurol. Neurosurg. Psychiatry 47, 912-916.
32. Uehara, K., Sugimoto, K., Wada, R., Yoshikawa, T., Marukawa, K., Yasuda, Y., Kimura, Y., Yagihashi, S., 1997. Effects of cilostazol on the peripheral nerve function and structure in STZ-induced diabetic rats. J. Diab. Comp. 11, 194-202.
33. Wright, A., Nukada, H., 1994. Sciatic nerve morphology and morphometry in mature rats with streptozocin-induced diabetes. Acta Neuropathol. (Berlin) 88, 571-578.
34. Yagihashi, S., 1995. Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab. Rev. 11, 193-225.
35. Zhong, W.W., Burke, P.A., Drotar, M.E., Chavali, S.R., Forse, R.A., 1995. Effects of prostaglandin E2, cholera toxin and 8-bromo-mcyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology 84, 446-452.
36. Zochodne, D.W., Ho, L.T., 1993. Diabetes mellitus prevents capsaicin from inducing hyperaemia in the rat sciatic nerve. Diabetologia 36, 493-496.